Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.0 USD 0.00(0%)
Last update at 2026-10-29T20:00:00Z
VOLUME
90000
Market Cap
0.01M

Momentum Score

…

Australis Capital Inc. operates as a cannabis company in the United States and internationally. The company was incorporated in 2018 and is based in Las Vegas, Nevada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
-
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Australis Capital Inc (AUSAF), quoted on the OTC Pink market, is limited and does not provide a clear description of ongoing business activities. Because long-term growth drivers are not publicly documented, investors may view the company as a speculative, low-transparency exposure that could benefit only from asset realization, restructuring, or improved disclosure.

Key risks include lack of transparent financial reporting, extremely low trading liquidity typical of Pink-sheet listings, potential for significant share dilution or corporate inactivity, and uncertainty about operational continuity.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
9.47M
Revenue Per Share
0.04
Gross Profit TTM
5.87M
Debt / Equity
0.01
ROE
-91.68%
Net Debt
-0.00M
ROCE
-36.79%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Type yearly yearly yearly yearly yearly
Date 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Income before tax -0.05M -0.03M -23.34M -4.17M -0.04M
Minority interest - 5.39M 5.39M 5.39M 5.39M
Net income -0.05M -0.03M -23.34M -4.17M -0.04M
Selling general administrative - 0.01M 13.65M 4.00M 0.00M
Selling and marketing expenses - 0.00M 0.37M 0.00M -
Gross profit 0.01M -0.00M 0.00M 0.13M 0.00M
Reconciled depreciation - - 0.60M 0.01M -
Ebit -0.02M -0.01M -12.85M -3.02M -0.00M
Ebitda -0.02M -0.01M -12.25M -3.01M 0.05M
Depreciation and amortization 0.00M 0.00M 0.60M 0.01M 0.05M
Non operating income net other - - - 0.00M 0.00M
Operating income -0.02M -0.01M -14.40M -4.29M -0.00M
Other operating expenses 0.06M 0.03M 14.62M 4.01M 0.00M
Interest expense 0.00M 0.00M 0.20M 0.46M 0.09M
Interest income - - 0.94M 0.28M 0.05M
Net interest income - - 0.74M -0.18M -0.04M
Extraordinary items - - - 0.00M 0.00M
Non recurring - - - 0.00M 0.00M
Other items - - - 0.00M 0.00M
Income tax expense 0.00M 0.00M 0.80M 1.04M 0.04M
Total revenue 0.01M 0.00M 0.22M 0.13M 0.00M
Total operating expenses 0.06M 0.03M 14.62M 4.01M 0.00M
Cost of revenue 0.00M 0.00M 0.22M 0.00M 0.00M
Total other income expense net -0.03M -0.01M -9.68M -0.11M 0.00M
Discontinued operations - - - 0.00M 0.00M
Net income from continuing ops - - -23.34M -4.17M -0.04M
Net income applicable to common shares -50.09M -25.26M -23.34M -4.17M -0.04M
Preferred stock and other adjustments - - - 0.00M 0.00M
Breakdown 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Type yearly yearly yearly yearly yearly
Date 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Total assets 0.06M 0.08M 63.70M 65.05M 3.01M
Intangible assets 0.03M 0.01M 14.78M 3.46M 0.00M
Other current assets 1.50M 16.96M 0.71M 0.71M 0.00M
Total liab 0.02M 0.02M 5.93M 4.38M 3.17M
Total stockholder equity 0.03M 0.05M 57.77M 60.67M -0.16M
Deferred long term liab - - - 0.00M 0.00M
Other current liab 0.00M 0.00M 0.29M 1.31M 0.00M
Common stock 0.03M 0.10M 74.65M 56.31M 0.00M
Capital stock - - 74.65M 56.31M -
Retained earnings - -0.05M -27.68M -4.33M -0.16M
Other liab 4.65M 6.90M 1.45M 2.74M 0.00M
Good will - 0.02M 0.59M 0.59M 0.00M
Other assets 0.02M 0.03M 7.15M 13.16M 0.00M
Cash 0.00M 0.00M 7.65M 5.58M 0.00M
Total current liabilities 0.01M 0.01M 3.88M 1.86M 3.17M
Current deferred revenue - - 1.47M -0.14M -
Net debt -0.00M -0.00M -6.90M -5.58M 3.14M
Short term debt - - 0.14M 0.14M 3.14M
Short long term debt - - - 0.00M 3.14M
Short long term debt total - - 0.75M 0.75M 3.14M
Other stockholder equity -0.03M -0.05M -0.05M -0.05M 0.00M
Property plant equipment 6.42M 1.40M 5.68M 0.12M 0.00M
Total current assets 0.01M 0.02M 23.72M 28.11M 3.01M
Long term investments - - 11.80M 16.84M 0.00M
Net tangible assets -7.63M 32.02M 42.40M 56.63M -0.16M
Short term investments - 0.00M 1.55M 2.93M 0.00M
Net receivables 4.44M 1.76M 0.43M 0.40M 3.01M
Long term debt - - - 0.00M 0.00M
Inventory 0.00M 0.00M 13.37M 18.50M 0.00M
Accounts payable 0.01M 0.00M 1.97M 0.56M 0.04M
Total permanent equity - - - 0.00M 0.00M
Noncontrolling interest in consolidated entity - - - 0.00M 0.00M
Temporary equity redeemable noncontrolling interests - - - 0.00M 0.00M
Accumulated other comprehensive income - - 0.53M 0.33M 0.00M
Additional paid in capital - - - 0.00M 0.00M
Common stock total equity - - - 0.00M 0.00M
Preferred stock total equity - - - 0.00M 0.00M
Retained earnings total equity - - - 0.00M 0.00M
Treasury stock - - - 0.00M 0.00M
Accumulated amortization - - - 0.00M 0.00M
Non currrent assets other -0.04M -0.03M -0.03M -0.02M 0.00M
Deferred long term asset charges - - - 0.00M 0.00M
Non current assets total 0.04M 0.03M 39.98M 36.94M 0.00M
Capital lease obligations - - 0.75M 0.00M 0.00M
Long term debt total - - - 0.00M 0.00M
Breakdown 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Type yearly yearly yearly yearly yearly
Date 2022-03-31 2021-03-31 2020-03-31 2019-03-31 2018-03-31
Investments - 0.49M -6.24M -18.12M -18.12M
Change to liabilities 0.00M 2.11M 0.93M 1.35M 0.00M
Total cashflows from investing activities 5.16M -2.92M -2.10M -25.36M -25.36M
Net borrowings - -0.20M -0.13M -0.13M 0.00M
Total cash from financing activities 0.01M -0.00M 2.27M 52.39M 0.00M
Change to operating activities - 0.53M -0.58M -0.44M 0.09M
Net income -0.05M -0.03M -23.34M -4.17M -0.04M
Change in cash -0.00M -0.01M -8.18M 5.58M -0.00M
Begin period cash flow 0.00M 0.02M 24.52M 24.52M 0.00M
End period cash flow 0.00M 0.00M 16.33M 5.58M 24.52M
Total cash from operating activities -0.01M -0.01M -8.32M -2.81M -0.00M
Issuance of capital stock - - 0.00M 48.63M -
Depreciation 0.00M 0.00M 0.60M 0.01M 0.01M
Other cashflows from investing activities 5.16M 5.16M 5.34M -5.34M -5.34M
Dividends paid - - - 0.00M 0.00M
Change to inventory - -0.00M -0.74M -0.28M -0.74M
Change to account receivables - 0.00M -0.03M -0.24M -0.05M
Sale purchase of stock - -0.00M -0.00M 0.00M 0.00M
Other cashflows from financing activities 0.01M -0.00M 2.40M 3.76M 0.50M
Change to netincome 34.22M 12.69M 14.01M 0.94M 0.94M
Capital expenditures 0.00M 0.00M 1.20M 0.13M 0.13M
Change receivables - - - 0.00M 0.00M
Cash flows other operating - - - 0.00M 0.00M
Exchange rate changes - - - 0.00M 0.00M
Cash and cash equivalents changes - - - 0.00M 0.00M
Change in working capital - -0.00M 0.52M 0.83M 0.04M
Stock based compensation 0.00M 0.00M 5.41M 0.68M -
Other non cash items 0.03M 0.02M -1.63M -1.42M -
Free cash flow -0.01M -0.01M -9.52M -2.94M -0.00M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MKKGY
Merck KGaA ADR
-0.01
0.03%
33.66 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
0.04
0.02%
169.25 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
0.90
4.50%
20.91 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
4.03
10.61%
42.00 - 10.66 0.01 1.16 2.94 23.11

Profile*

Australis Capital Inc

Australis Capital Inc. operates as a cannabis company in the United States and internationally. The company was incorporated in 2018 and is based in Las Vegas, Nevada.

376 East Warm Springs Road, Las Vegas, NV, United States, 89119

800 898 0648

Name Title Year Born
Mr. Terrance R. Booth CEO & Director 1965
Mr. Jon Paul Chief Financial Officer NA
Dr. Jason Ronald Bradley Dyck Ph.D. Chief Science Officer, Chairman of Scientific Advisory Board & Director 1969
Ms. Leah S. Bailey Chief Bus. Devel. Officer 1956
Mr. Roger Sykes Chief Operating Officer NA
Mr. Brent Edwin Reuter Sr. VP of Investor Relations & Strategy 1967
Mr. Paul E. Larsen Gen. Counsel NA
Mr. Marc Lakmaaker Sr. VP of Communications & Capital Markets NA
Mr. Fausto Aceituno Aceituno Chief Marketing Officer NA
Thomas Larssen Pres of ALPS NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…